About this role
Director, Integrated Insights for Liver & Inflammation Pipeline
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercialises innovative medicines in areas of unmet medical need. With each new discovery and investigational drug candidate, we seek to improve the care of patients living with life-threatening diseases around the world. Gilead’s therapeutic areas of focus include HIV/AIDS, liver diseases, cancer, inflammation and serious respiratory conditions. For more information please visit Gilead.com
An exciting opportunity has arisen within the Global Decision Sciences & Insights team for a Director, Integrated Insights for Liver & Inflammation Pipeline.
Inflammation/ Liver is a priority development area in Gilead. With the maturation of the inflam/ liver pipeline and the recent/ ongoing M&A activities in the inflame/ liver portfolio, the need to provide commercial perspective on inflam/ liver pipeline development increases significantly. This role will drive primarily pipeline integrated insights (i.e., forecasting, market research, analytics) activities for liver and inflame portfolio. From internal pipeline perspective, we have a strong pipeline in disease areas including but not limited to HDV, IBD, SLE, Asthma, AD. In addition, with the recent acquisition of Ouro, there are more than 20+ indications that are under evaluation for development. This role will have a large variety of pipeline work to shape the future of Gilead presence in liver/ inflammation. This candidate will work close with the global marketing team, clinical team to inform critical commercial decisions as assets progress